Wird geladen...
PPARα Agonist Oral Therapy in Diabetic Retinopathy
Diabetic retinopathy (DR) is an eye condition that develops after chronically poorly-managed diabetes, and is presently the main cause for blindness on a global scale. Current treatments for DR such as laser photocoagulation, topical injection of corticosteroids, intravitreal injection of anti-vascu...
Gespeichert in:
| Veröffentlicht in: | Biomedicines |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7589723/ https://ncbi.nlm.nih.gov/pubmed/33086679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines8100433 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|